Order Article Reprints

Șandor A, Crișan O, Marc G, Fizeșan I, Ionuț I, Moldovan C, Stana A, Oniga I, Pîrnău A, Vlase L, et al. Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors. Pharmaceutics. 2025; 17(2):260. https://doi.org/10.3390/pharmaceutics17020260

Șandor, Alexandru, Ovidiu Crișan, Gabriel Marc, Ionel Fizeșan, Ioana Ionuț, Cristina Moldovan, Anca Stana, Ilioara Oniga, Adrian Pîrnău, Laurian Vlase, and et al. 2025. "Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors" Pharmaceutics 17, no. 2: 260. https://doi.org/10.3390/pharmaceutics17020260

Șandor, A., Crișan, O., Marc, G., Fizeșan, I., Ionuț, I., Moldovan, C., Stana, A., Oniga, I., Pîrnău, A., Vlase, L., Petru, A.-E., Creștin, I.-V., Jîjie, A.-R., Tiperciuc, B., & Oniga, O. (2025). Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors. Pharmaceutics, 17(2), 260. https://doi.org/10.3390/pharmaceutics17020260